Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo

 

Now Available: 50 Disruptive Companies 2013 See The 2013 List »

The 50 Most Innovative Companies 2011

Biomedicine

Private Companies

BIND Biosciences

Why: Targeting cancer drugs narrowly to tumor cells will improve efficacy and reduce the side effects of chemotherapy.
Key innovation: Its delivery system uses engineered nanoparticles to deliver drugs to specific cells.

Cellular Dynamics International

Why: Screening drugs on human heart cells will help researchers find treatments for cardiac problems and test drugs for toxic side effects.
Key innovation: Uses included pluripotent stems cells to make large numbers of heart cells for testing.

Claros Diagnostics

Why: Simple, fast diagnostic tests can help physicians track disease-related markers.
Key innovation: Its microfluidic device for doctors' offices can quickly detect elevated protein levels associated with prostate cancer.